Rockwell Medical Announces Transformational Global Hemodialysis Acquisition

Mark Strobeck, President and Chief Executive Officer at Rockwell Medical

“Acquiring Vantive’s hemodialysis assets and associated operations represents a transformative step in Rockwell Medical’s evolution and directly advances the strategy we have been executing over the past several years.”

Mark Strobeck, President and Chief Executive Officer at Rockwell Medical

“This transaction has the potential to accelerate the next phase of our growth by adding meaningful product breadth, global distribution, manufacturing and R&D infrastructure, technical service capabilities and recurring revenue streams that would take years to build organically.”

Mark Strobeck, President and Chief Executive Officer at Rockwell Medical

“We believe the combined businesses will expand our ability to serve dialysis providers and patients across the global hemodialysis ecosystem and creates a stronger platform for growth, innovation and long-term value creation for customers, patients, employees and shareholders.”

Chris Toth, Chief Executive Officer at Vantive

“Our priority has been to identify the right buyer that understands the importance of continuity for customers, patients and employees.”

Chris Toth, Chief Executive Officer at Vantive

“Rockwell Medical’s singular focus on hemodialysis, operating experience and commitment to investing in people and capabilities provide a strong foundation for the next chapter of these hemodialysis assets and operations.”

Chris Toth, Chief Executive Officer at Vantive

“We believe this transaction will build on the progress our teams have made, while helping to create new and expanded opportunities for customers, patients and employees, and we are committed to supporting a smooth transition.”